Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma TrialLucas Moreno, Rebekah Weston, Cormac Owens et al.|Journal of Clinical Oncology|2024Cited by 25
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II TrialJuliet C. Gray, Lucas Moreno, Rebekah Weston et al.|Journal of Clinical Oncology|2025Cited by 8
Landscape of early clinical trials for childhood and adolescence cancer in SpainFrancisco Bautista, Lucas Moreno, Luís Madero et al.|Clinical & Translational Oncology|2015Cited by 7
ECLIM-SEHOP, a new platform to set up and develop international academic clinical trials for childhood cancer and blood disorders in SpainAna Fernández‐Teijeiro, Francisco Bautista, Adela Cañete et al.|Clinical & Translational Oncology|2019Cited by 5
Ensayos clínicos precoces en oncología pediátrica en España: una perspectiva nacionalFrancisco Bautista, Lucas Moreno, Soledad Gallego et al.|Anales de Pediatría|2017Cited by 3